Buchumschlag

Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jennifer Longoria, Andrew Heitzer, Jane Hankins
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Pediatric Blood & Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
von: Wei‐Zhen Tang, et al.
Veröffentlicht: (2024)

“I was very scared when I found out my son had sickle cell”: Caregiver knowledge and attitudes toward early intervention for young children with sickle cell disease: Implications for policy and practice from a multi‐site study
von: Catherine R. Hoyt, et al.
Veröffentlicht: (2024)

Experiences and outcomes of fertility testing in male adolescents with sickle cell disease
von: Susan Creary, et al.
Veröffentlicht: (2024)

Quantifying dilated perivascular spaces in children with sickle cell disease
von: Kristine A. Karkoska, et al.
Veröffentlicht: (2024)

Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population‐based study
von: Jiajing Scarlette Shi, et al.
Veröffentlicht: (2024)

Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States
von: Fathia Oladipupo, et al.
Veröffentlicht: (2024)

Sexually transmitted infection testing and diagnosis in adolescents and young adults with sickle cell disease
von: Joseph Walden, et al.
Veröffentlicht: (2024)

Association of hydroxyurea adherence with transcranial Doppler screenings in children with sickle cell disease
von: La'Kita M. J. Knight, et al.
Veröffentlicht: (2024)

Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan
von: Reema Kashif, et al.
Veröffentlicht: (2024)

Description of a national, multi‐center registry of patients with sickle cell disease and SARS‐CoV‐2 infection: Data from the Pediatric COVID‐19 United States Registry
von: Aleksandra S. Dain, et al.
Veröffentlicht: (2024)

Patterns of primary and specialty care among children with sickle cell anemia
von: Pooja N. Patel, et al.
Veröffentlicht: (2024)

Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project
von: Jeffrey G. Edwards, et al.
Veröffentlicht: (2024)

“Everyone screens to some extent”: Barriers and facilitators of developmental screening among children with sickle cell disease: A mixed methods study
von: Catherine R. Hoyt, et al.
Veröffentlicht: (2024)

Pain screening in youth with sickle cell disease: A quality improvement study
von: Dennis C. Vroom, et al.
Veröffentlicht: (2024)

Oncofertility care for children, adolescents, and young adults at risk for treatment‐related fertility loss
von: Lindsay Talbot, et al.
Veröffentlicht: (2024)

Statewide Academic Performance of High School Students With Sickle Cell Disease
von: Andrew M. Heitzer, et al.
Veröffentlicht: (2025)

Psychiatry referral and appointment attendance in a clinic for young adults with sickle cell disease
von: Elizabeth J. Prince, et al.
Veröffentlicht: (2024)

Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
von: Erfan Taherifard, et al.
Veröffentlicht: (2024)

Growing teratoma syndrome in children and adolescents: Prevalence and surgical outcome
von: Federico Beati, et al.
Veröffentlicht: (2024)

SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team
von: Robyn T. Cohen, et al.
Veröffentlicht: (2024)

The relationship between cumulative risk and health‐related quality of life in youth with sickle cell disease: Moderating effects of secondary control engagement coping
von: Elise M. Belkin, et al.
Veröffentlicht: (2024)

Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
von: Zachary Abramson, et al.
Veröffentlicht: (2025)

Characterizing medical decision‐making in sickle cell disease during childhood: Qualitative perspectives of caregivers
von: Ariel O. Blakey, et al.
Veröffentlicht: (2024)

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes
von: Cristina Larrosa, et al.
Veröffentlicht: (2024)

Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer
von: Gabriel Revon‐Riviere, et al.
Veröffentlicht: (2024)

A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant
von: Michelle Amit, et al.
Veröffentlicht: (2024)

Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
von: Ajibike Lapite, et al.
Veröffentlicht: (2024)

The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study
von: Kemar V. Prussien, et al.
Veröffentlicht: (2024)

Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records
von: Arlene Smaldone, et al.
Veröffentlicht: (2024)

Emergency department 30‐Day emergency department revisits among people with sickle cell disease: Variations in characteristics
von: Melinda Rushing, et al.
Veröffentlicht: (2024)

Comment on: “Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease”: Participant evaluation
von: Mary F. Martin, et al.
Veröffentlicht: (2024)

Body composition analysis using dual‐energy x‐ray absorptiometry in an Egyptian pediatric sickle cell disease cohort
von: Ahmed Maher Kaddah, et al.
Veröffentlicht: (2024)

Targeting BCL11A through gene therapy in sickle cell disease: Will one size fit all or most?
von: Abdulrahman Alsultan
Veröffentlicht: (2024)

Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity
von: Mona Hamdy, et al.
Veröffentlicht: (2024)

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia
von: Zsuzsanna Gaál, et al.
Veröffentlicht: (2026)

Cancer is not a risk factor for severe COVID‐19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities
von: Pablo Velasco Puyó, et al.
Veröffentlicht: (2024)

COVID‐19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies
von: Blake Foxworthy, et al.
Veröffentlicht: (2024)

Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord‐stromal tumors. Results of the TGM13 National Registry
von: Clemence Fuentes, et al.
Veröffentlicht: (2024)

Informing parents of newborns with sickle cell trait detected at neonatal screening: A northern France experience
von: Malo Freppel, et al.
Veröffentlicht: (2024)

Spiritual needs of children and adolescents with cancer at the end of life
von: Hüseyin Çaksen
Veröffentlicht: (2024)